Chemoinformaics analysis of GLYCYRRHETIC-ACID
| Molecular Weight | 470.694 | nRot | 1 |
| Heavy Atom Molecular Weight | 424.326 | nRig | 28 |
| Exact Molecular Weight | 470.34 | nRing | 5 |
| Solubility: LogS | -4.509 | nHRing | 0 |
| Solubility: LogP | 4.849 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 83.9805 |
| nHD | 2 | BPOL | 47.8835 |
| QED | 0.426 |
| Synth | 4.968 |
| Natural Product Likeliness | 2.729 |
| NR-PPAR-gamma | 0.985 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.043 |
| Pgp-sub | 0.001 |
| HIA | 0.022 |
| CACO-2 | -5.415 |
| MDCK | 0.0000161 |
| BBB | 0.733 |
| PPB | 0.930858 |
| VDSS | 0.835 |
| FU | 0.0445973 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.586 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.138 |
| CYP2c9-sub | 0.389 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.199 |
| CYP3a4-sub | 0.482 |
| CL | 2.525 |
| T12 | 0.065 |
| hERG | 0.001 |
| Ames | 0.126 |
| ROA | 0.171 |
| SkinSen | 0.019 |
| Carcinogencity | 0.016 |
| EI | 0.545 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.747 |
| Antiviral | No |
| Prediction | 0.741164 |